WILLIAM NGUYEN: Open Payments
NPI 1689316523 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 15 payments from 9 companies in 2025. Trend: 2023 $1,004 · 2024 $1,028 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $109 |
| Radius Health, Inc. | 3 | $80 |
| Novo Nordisk Inc | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: ELIQUIS, Tymlos, EVKEEZA, Wegovy, SHINGRIX, Ozempic, ACCRUFER, JARDIANCE.
Industry payments across CA — which companies pay providers there.
